3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Pancreatic Neoplasms
7
Neoplasm Metastasis
2
Adenocarcinoma
2
Pancreatic Ductal Adenocarcinoma (PDAC)
1
Neoplasms
1
Locally Advanced Unresectable or Metastatic Solid Tumors
1
Gastroesophageal Adenocarcinoma
1
Carcinoma
1
Interventions
Carboplatin
9
pembrolizumab
8
Paclitaxel
8
Cisplatin
8
Radiotherapy, Intensity-Modulated
6
Magnetic Resonance Spectroscopy
6
Gemcitabine
5
fludarabine
4
Specimen Handling
4
Pemetrexed
4
Nivolumab
4
Cyclophosphamide
4
trebananib
3
osimertinib
3
liposomal doxorubicin
3
Radiotherapy
3
Interleukin-2
3
Fluorouracil
3
Docetaxel
3
DNA
3
volociximab
2
poly ICLC
2
lenvatinib
2
fludarabine phosphate
2
Sorafenib
2
Radiosurgery
2
Midazolam
2
Capecitabine
2
Biopsy
2
Bevacizumab
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Carcinoma
×
folfirinox
×
Clear all
NCT04990037
2023-06-29
CAPAFOUR
Cantargia AB
Phase 1
Completed
25 enrolled